NanoGroup S.A. (WSE: NNG)

Market Cap	69.03M
Revenue (ttm)	1.02K
Net Income (ttm)	-7.12M
Shares Out	24.22M
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,648
Open	2.740
Previous Close	2.740
Day's Range	2.740 - 2.990
52-Week Range	0.882 - 4.370
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2023, NanoGroup's revenue was 2,019, a decrease of -98.55% compared to the previous year's 139,549. Losses were -7.89 million, 840.8% more than in 2022.